LC-MS-Based Metabolomics in Drug Metabolism
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Xenobiotic metabolism, a ubiquitous natural response to foreign compounds, elicits initiating signals for many pathophysiological events. Currently, most widely used techniques for identifying xenobiotic metabolites and metabolic pathways are empirical and largely based on in vitro incubation assays and in vivo radiotracing experiments. Recent work in our lab has shown that LC-MS-based metabolomic techniques are useful tools for xenobiotic metabolism research since multivariate data analysis in metabolomics can significantly rationalize the processes of xenobiotic metabolite identification and metabolic pathway analysis. In this review, the technological elements of LC-MS-based metabolomics for constructing high-quality datasets and conducting comprehensive data analysis are examined. Four novel approaches of using LC-MS-based metabolomic techniques in xenobiotic metabolism research are proposed and illustrated by case studies and proof-of-concept experiments, and the perspective on their application is further discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Mass spectrometry‐based metabolomics
Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20108 · Cited by 2,241
Metabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Trygg, J., Holmes, E., & Lundstedt, T. (2007) · Journal of Proteome Research · doi:10.1021/pr060594q · Cited by 1,273
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91430-1 · Cited by 1,183
Self-citationUnderstanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism
Nicholson, J. K., & Wilson, I. D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1157 · Cited by 1,116
Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., McKilligin, E., Mosedale, D. E., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-802 · Cited by 1,029
Metabolite profiling: from diagnostics to systems biology
Fernie, A. R., Trethewey, R. N., Krotzky, A. J., & Willmitzer, L. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1451 · Cited by 844
Pharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824 · cited 1×
“Therefore, the information obtained from studying the metabolic pathways related to ADRs may help to identify the patients susceptible to ADR and promote the transformation of empirical medication to individualized medication (Clayton et al., 2006; Nebert and Vesell, 2006).”
BackgroundAndo, Y., Saka, H., Ando, M., Sawa, T., Muro, K., Ueoka, H., Yokoyama, A., Saitoh, S., Shimokata, K., & Hasegawa, Y. (2000) · PubMed · Cited by 783
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
Gonzalez, F. J., Skodat, R. C., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., & Meyer, U. A. (1988) · Nature · doi:10.1038/331442a0 · Cited by 715
Self-citationData processing for mass spectrometry-based metabolomics
Katajamaa, M., & Orešič, M. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.04.021 · Cited by 616 · cited 1×
“Appropriate data processing is required to prepare chromatographic and spectral data for MDA (Katajamaa and Oresic, 2007).”
MethodNear Completely Humanized Liver in Mice Shows Human-Type Metabolic Responses to Drugs
Tateno, C., Yoshizane, Y., Saito, N., Kataoka, M., Utoh, R., Yamasaki, C., Tachibana, A., Soeno, Y., Asahina, K., Hino, H., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63352-4 · Cited by 548
Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics
Pan, Z., & Raftery, D. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0687-8 · Cited by 444
Plant metabolomics: towards biological function and mechanism
SCHAUER, N., & FERNIE, A. (2006) · Trends in Plant Science · doi:10.1016/j.tplants.2006.08.007 · Cited by 434
Wilson, I. D., Nicholson, J. K., Castro-Perez, J., Granger, J. H., Johnson, K. A., Smith, B. W., & Plumb, R. S. (2005) · Journal of Proteome Research · doi:10.1021/pr049769r · Cited by 420
Normalization method for metabolomics data using optimal selection of multiple internal standards
Sysi-Aho, M., Katajamaa, M., Yetukuri, L., & Orešič, M. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-93 · Cited by 358
Giacomini, K. M., Krauss, R. M., Roden, D. M., Eichelbaum, M., Hayden, M. R., & Nakamura, Y. (2007) · Nature · doi:10.1038/446975a · Cited by 276
From Exogenous to Endogenous: The Inevitable Imprint of Mass Spectrometry in Metabolomics
Want, E. J., Nordström, A., Morita, H., & Siuzdak, G. (2007) · Journal of Proteome Research · doi:10.1021/pr060505+ · Cited by 261
Henderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212087200 · Cited by 258
Yun, C. H., Okerholm, R. A., & Guengerich, F. P. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07393-3 · Cited by 229
Zhu, M., Ma, L., Zhang, D., Ray, K., Zhao, W., Humphreys, W. G., Skiles, G., Sanders, M., & Zhang, H. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009241 · Cited by 227
Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions
Wang, L., & Weinshilboum, R. (2006) · Oncogene · doi:10.1038/sj.onc.1209372 · Cited by 225
Plumb, R. S., Stumpf, C. L., Granger, J. H., Castro‐Perez, J., Haselden, J. N., & Dear, G. J. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1250 · Cited by 193
Giri, S., Idle, J. R., Chen, C., Zabriskie, T. M., Krausz, K. W., & Gonzalez, F. J. (2006) · Chemical Research in Toxicology · doi:10.1021/tx0600402 · Cited by 171
Self-citationTHE FATE OF ACETANILIDE IN MAN
Brodie, B. B., & Axelrod, J. (1948) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03462-7 · Cited by 168 · cited 2×
“In fact, identification of biologically active metabolites led to the development of safer and more potent drugs, such as acetaminophen from acetanilide (Brodie and Axelrod, 1948) and fexofenadine from terfenadine (Yun et al.”
BackgroundMicrobial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets
WERF, M. J. V. D., Jellema, R. H., & Hankemeier, T. (2005) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-005-0231-4 · Cited by 168
Drug Metabolism and Drug Interactions: Application and Clinical Value of In Vitro Models
Venkatakrishnan, K., von Moltke, L., Obach, R., & Greenblatt, D. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489361 · Cited by 162
CYTOCHROME P450 AND XENOBIOTIC RECEPTOR HUMANIZED MICE
Gonzalez, F. J., & Yu, A. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100007 · Cited by 160
Self-citationGriffin, J. L. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1734 · Cited by 158
Stable Isotope Labeling of Arabidopsis thaliana for an NMR-Based Metabolomics Approach
Kikuchi, J., Shinozaki, K., & Hirayama, T. (2004) · Plant and Cell Physiology · doi:10.1093/pcp/pch117 · Cited by 147
Metabolic Profiling Technologies for Biomarker Discovery in Biomedicine and Drug Development
Schlotterbeck, G., Ross, A., Dieterle, F., & Senn, H. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.1055 · Cited by 95
Computational prediction of human drug metabolism
Ekins, S., Andreyev, S., Ryabov, A., Kirillov, E., Rakhmatulin, E. A., Bugrim, A. E., & Nikolskaya, T. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.303 · Cited by 93
Giri, S., Krausz, K. W., Idle, J. R., & Gonzalez, F. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.017 · Cited by 72
Self-citationChen, C., Ma, X., Malfatti, M. A., Krausz, K. W., Kimura, S., Felton, J. S., Idle, J. R., & Gonzalez, F. J. (2007) · Chemical Research in Toxicology · doi:10.1021/tx600320w · Cited by 65
Self-citationUrinary Metabolite Profiling Reveals CYP1A2-Mediated Metabolism of NSC686288 (Aminoflavone)
Chen, C., Meng, L., Ma, X., Krausz, K. W., Pommier, Y. G., Idle, J. R., & Gonzalez, F. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105213 · Cited by 58
Self-citationRole of Gene Knockout and Transgenic Mice in the Study of Xenobiotic Metabolism
Gonzalez, F. J. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026496 · Cited by 57
Self-citationKristal, B. S., Shurubor, Y. I., Kaddurah-Daouk, R. F., & Matson, W. R. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-244-1_10 · Cited by 56
Application of Chimeric Mice with Humanized Liver for Predictive ADME
Katoh, M., & Yokoi, T. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601021340 · Cited by 51
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.
Nebert, D., & Vesell, E. (2006) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.008 · Cited by 45
Cytochrome P450 humanised mice
Gonzalez, F. J. (2004) · Human Genomics · doi:10.1186/1479-7364-1-4-300 · Cited by 36
Self-citationAchievement of a 920-MHz High Resolution NMR
Hashi, K., Shimizu, T., Goto, A., Kiyoshi, T., Matsumoto, S., Wada, H., Fujito, T., Hasegawa, K.-I., Yoshikawa, M., Miki, T., et al. (2002) · Journal of Magnetic Resonance · doi:10.1006/jmre.2002.2559 · Cited by 28
Zhen, Y., Slanař, O., Krausz, K. W., Chen, C., Slavík, J., McPhail, K. L., Zabriskie, T. M., Perlík, F., Gonzalez, F. J., & Idle, J. R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008920 · Cited by 14
Self-citation
Cited by
Emerging applications of metabolomics in drug discovery and precision medicine
Wishart, D. S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.32 · Cited by 1,488
Vuckovic, D. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6039-y · Cited by 532
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B., & Yan, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019393108 · Cited by 449
Lankadurai, B. P., Nagato, E. G., & Simpson, M. J. (2013) · Environmental Reviews · doi:10.1139/er-2013-0011 · Cited by 385
Dunn, W. B. (2008) · Physical Biology · doi:10.1088/1478-3975/5/1/011001 · Cited by 278
Metadata
- Authors
- Chen, C., Gonzalez, F. J., & Idle, J. R.
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 39
- Issue
- 2-3
- Pages
- 581-597
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2156613862
- Cited by
- 260
- References
- 45
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.